ALCAM and cancer: Tongue squamous cell carcinoma cells with UBE2C silencing exhibit lowered expression of the cancer stemness markers ALDH1/A2, CD44, CD166 and EpCAM, indicating the role of UBE2C in controlling the cancer stemness [32].